Literature DB >> 30849372

Characterizing Mutational Signatures in Human Cancer Cell Lines Reveals Episodic APOBEC Mutagenesis.

Mia Petljak1, Ludmil B Alexandrov2, Jonathan S Brammeld1, Stacey Price1, David C Wedge3, Sebastian Grossmann1, Kevin J Dawson1, Young Seok Ju4, Francesco Iorio5, Jose M C Tubio6, Ching Chiek Koh1, Ilias Georgakopoulos-Soares1, Bernardo Rodríguez-Martín7, Burçak Otlu8, Sarah O'Meara1, Adam P Butler1, Andrew Menzies1, Shriram G Bhosle1, Keiran Raine1, David R Jones1, Jon W Teague1, Kathryn Beal1, Calli Latimer1, Laura O'Neill1, Jorge Zamora7, Elizabeth Anderson1, Nikita Patel1, Mark Maddison1, Bee Ling Ng9, Jennifer Graham9, Mathew J Garnett1, Ultan McDermott1, Serena Nik-Zainal10, Peter J Campbell1, Michael R Stratton11.   

Abstract

Multiple signatures of somatic mutations have been identified in cancer genomes. Exome sequences of 1,001 human cancer cell lines and 577 xenografts revealed most common mutational signatures, indicating past activity of the underlying processes, usually in appropriate cancer types. To investigate ongoing patterns of mutational-signature generation, cell lines were cultured for extended periods and subsequently DNA sequenced. Signatures of discontinued exposures, including tobacco smoke and ultraviolet light, were not generated in vitro. Signatures of normal and defective DNA repair and replication continued to be generated at roughly stable mutation rates. Signatures of APOBEC cytidine deaminase DNA-editing exhibited substantial fluctuations in mutation rate over time with episodic bursts of mutations. The initiating factors for the bursts are unclear, although retrotransposon mobilization may contribute. The examined cell lines constitute a resource of live experimental models of mutational processes, which potentially retain patterns of activity and regulation operative in primary human cancers. Crown
Copyright © 2019. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  APOBEC deaminases; cancer cell lines; episodic mutagenesis; mutational signatures; xenografts

Mesh:

Substances:

Year:  2019        PMID: 30849372      PMCID: PMC6424819          DOI: 10.1016/j.cell.2019.02.012

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  67 in total

1.  An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers.

Authors:  Steven A Roberts; Michael S Lawrence; Leszek J Klimczak; Sara A Grimm; David Fargo; Petar Stojanov; Adam Kiezun; Gregory V Kryukov; Scott L Carter; Gordon Saksena; Shawn Harris; Ruchir R Shah; Michael A Resnick; Gad Getz; Dmitry A Gordenin
Journal:  Nat Genet       Date:  2013-07-14       Impact factor: 38.330

2.  Clustered mutations in yeast and in human cancers can arise from damaged long single-strand DNA regions.

Authors:  Steven A Roberts; Joan Sterling; Cole Thompson; Shawn Harris; Deepak Mav; Ruchir Shah; Leszek J Klimczak; Gregory V Kryukov; Ewa Malc; Piotr A Mieczkowski; Michael A Resnick; Dmitry A Gordenin
Journal:  Mol Cell       Date:  2012-05-17       Impact factor: 17.970

3.  Association of germline variants in the APOBEC3 region with cancer risk and enrichment with APOBEC-signature mutations in tumors.

Authors:  Candace D Middlebrooks; A Rouf Banday; Konichi Matsuda; Krizia-Ivana Udquim; Olusegun O Onabajo; Ashley Paquin; Jonine D Figueroa; Bin Zhu; Stella Koutros; Michiaki Kubo; Taro Shuin; Neal D Freedman; Manolis Kogevinas; Nuria Malats; Stephen J Chanock; Montserrat Garcia-Closas; Debra T Silverman; Nathaniel Rothman; Ludmila Prokunina-Olsson
Journal:  Nat Genet       Date:  2016-09-19       Impact factor: 38.330

Review 4.  Molecular mechanisms of antibody somatic hypermutation.

Authors:  Javier M Di Noia; Michael S Neuberger
Journal:  Annu Rev Biochem       Date:  2007       Impact factor: 23.643

5.  Base damage within single-strand DNA underlies in vivo hypermutability induced by a ubiquitous environmental agent.

Authors:  Kin Chan; Joan F Sterling; Steven A Roberts; Ashok S Bhagwat; Michael A Resnick; Dmitry A Gordenin
Journal:  PLoS Genet       Date:  2012-12-13       Impact factor: 5.917

6.  Mutation Signatures Including APOBEC in Cancer Cell Lines.

Authors:  Matthew C Jarvis; Diako Ebrahimi; Nuri A Temiz; Reuben S Harris
Journal:  JNCI Cancer Spectr       Date:  2018-03-17

7.  An integrated map of genetic variation from 1,092 human genomes.

Authors:  Goncalo R Abecasis; Adam Auton; Lisa D Brooks; Mark A DePristo; Richard M Durbin; Robert E Handsaker; Hyun Min Kang; Gabor T Marth; Gil A McVean
Journal:  Nature       Date:  2012-11-01       Impact factor: 49.962

8.  Timing, rates and spectra of human germline mutation.

Authors:  Raheleh Rahbari; Arthur Wuster; Sarah J Lindsay; Robert J Hardwick; Ludmil B Alexandrov; Saeed Al Turki; Anna Dominiczak; Andrew Morris; David Porteous; Blair Smith; Michael R Stratton; Matthew E Hurles
Journal:  Nat Genet       Date:  2015-12-14       Impact factor: 38.330

9.  Landscape of somatic mutations in 560 breast cancer whole-genome sequences.

Authors:  Serena Nik-Zainal; Helen Davies; Johan Staaf; Manasa Ramakrishna; Dominik Glodzik; Xueqing Zou; Inigo Martincorena; Ludmil B Alexandrov; Sancha Martin; David C Wedge; Peter Van Loo; Young Seok Ju; Marcel Smid; Arie B Brinkman; Sandro Morganella; Miriam R Aure; Ole Christian Lingjærde; Anita Langerød; Markus Ringnér; Sung-Min Ahn; Sandrine Boyault; Jane E Brock; Annegien Broeks; Adam Butler; Christine Desmedt; Luc Dirix; Serge Dronov; Aquila Fatima; John A Foekens; Moritz Gerstung; Gerrit K J Hooijer; Se Jin Jang; David R Jones; Hyung-Yong Kim; Tari A King; Savitri Krishnamurthy; Hee Jin Lee; Jeong-Yeon Lee; Yilong Li; Stuart McLaren; Andrew Menzies; Ville Mustonen; Sarah O'Meara; Iris Pauporté; Xavier Pivot; Colin A Purdie; Keiran Raine; Kamna Ramakrishnan; F Germán Rodríguez-González; Gilles Romieu; Anieta M Sieuwerts; Peter T Simpson; Rebecca Shepherd; Lucy Stebbings; Olafur A Stefansson; Jon Teague; Stefania Tommasi; Isabelle Treilleux; Gert G Van den Eynden; Peter Vermeulen; Anne Vincent-Salomon; Lucy Yates; Carlos Caldas; Laura van't Veer; Andrew Tutt; Stian Knappskog; Benita Kiat Tee Tan; Jos Jonkers; Åke Borg; Naoto T Ueno; Christos Sotiriou; Alain Viari; P Andrew Futreal; Peter J Campbell; Paul N Span; Steven Van Laere; Sunil R Lakhani; Jorunn E Eyfjord; Alastair M Thompson; Ewan Birney; Hendrik G Stunnenberg; Marc J van de Vijver; John W M Martens; Anne-Lise Børresen-Dale; Andrea L Richardson; Gu Kong; Gilles Thomas; Michael R Stratton
Journal:  Nature       Date:  2016-05-02       Impact factor: 49.962

10.  Distinct mutational signatures characterize concurrent loss of polymerase proofreading and mismatch repair.

Authors:  N J Haradhvala; J Kim; Y E Maruvka; P Polak; D Rosebrock; D Livitz; J M Hess; I Leshchiner; A Kamburov; K W Mouw; M S Lawrence; G Getz
Journal:  Nat Commun       Date:  2018-05-01       Impact factor: 14.919

View more
  120 in total

1.  ER-directed TREX1 limits cGAS activation at micronuclei.

Authors:  Lisa Mohr; Eléonore Toufektchan; Patrick von Morgen; Kevan Chu; Aakanksha Kapoor; John Maciejowski
Journal:  Mol Cell       Date:  2021-01-20       Impact factor: 17.970

2.  Somatic genetic aberrations in benign breast disease and the risk of subsequent breast cancer.

Authors:  Zexian Zeng; Andy Vo; Xiaoyu Li; Ali Shidfar; Paulette Saldana; Luis Blanco; Xiaoling Xuei; Yuan Luo; Seema A Khan; Susan E Clare
Journal:  NPJ Breast Cancer       Date:  2020-06-12

Review 3.  The spectrum of APOBEC3 activity: From anti-viral agents to anti-cancer opportunities.

Authors:  Abby M Green; Matthew D Weitzman
Journal:  DNA Repair (Amst)       Date:  2019-09-13

Review 4.  The duality of human oncoproteins: drivers of cancer and congenital disorders.

Authors:  Pau Castel; Katherine A Rauen; Frank McCormick
Journal:  Nat Rev Cancer       Date:  2020-04-27       Impact factor: 60.716

5.  Genome aging: somatic mutation in the brain links age-related decline with disease and nominates pathogenic mechanisms.

Authors:  Michael A Lodato; Christopher A Walsh
Journal:  Hum Mol Genet       Date:  2019-10-15       Impact factor: 6.150

Review 6.  The case for BK polyomavirus as a cause of bladder cancer.

Authors:  Gabriel J Starrett; Christopher B Buck
Journal:  Curr Opin Virol       Date:  2019-07-20       Impact factor: 7.090

7.  Cancers from Novel Pole-Mutant Mouse Models Provide Insights into Polymerase-Mediated Hypermutagenesis and Immune Checkpoint Blockade.

Authors:  Melissa A Galati; Karl P Hodel; Zachary F Pursell; Uri Tabori; Miki S Gams; Sumedha Sudhaman; Taylor Bridge; Walter J Zahurancik; Nathan A Ungerleider; Vivian S Park; Ayse B Ercan; Lazar Joksimovic; Iram Siddiqui; Robert Siddaway; Melissa Edwards; Richard de Borja; Dana Elshaer; Jiil Chung; Victoria J Forster; Nuno M Nunes; Melyssa Aronson; Xia Wang; Jagadeesh Ramdas; Andrea Seeley; Tomasz Sarosiek; Gavin P Dunn; Jonathan N Byrd; Oz Mordechai; Carol Durno; Alberto Martin; Adam Shlien; Eric Bouffet; Zucai Suo; James G Jackson; Cynthia E Hawkins; Cynthia J Guidos
Journal:  Cancer Res       Date:  2020-09-16       Impact factor: 12.701

Review 8.  Molecular origins of APOBEC-associated mutations in cancer.

Authors:  Mia Petljak; John Maciejowski
Journal:  DNA Repair (Amst)       Date:  2020-07-06

Review 9.  The origin of human mutation in light of genomic data.

Authors:  Vladimir B Seplyarskiy; Shamil Sunyaev
Journal:  Nat Rev Genet       Date:  2021-06-23       Impact factor: 53.242

10.  Characterization of systemic genomic instability in budding yeast.

Authors:  Nadia M V Sampaio; V P Ajith; Ruth A Watson; Lydia R Heasley; Parijat Chakraborty; Aline Rodrigues-Prause; Ewa P Malc; Piotr A Mieczkowski; Koodali T Nishant; Juan Lucas Argueso
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-26       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.